Cite
MLA Citation
Thomas Vanassche et al.. “Reversal of dabigatran by idarucizumab: when and how?.” Expert review of hematology, vol. 9, no. 6, 2016, pp. 519–528. http://access.bl.uk/ark:/81055/vdc_100033828448.0x000049
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Thomas Vanassche et al.. “Reversal of dabigatran by idarucizumab: when and how?.” Expert review of hematology, vol. 9, no. 6, 2016, pp. 519–528. http://access.bl.uk/ark:/81055/vdc_100033828448.0x000049